Immunogen (IMGN) Misses Q3 EPS by 42c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
ImmunoGen Reports Recent Progress and Third Quarter 2017 Operating Results
November 3, 2017 6:30 AM EDTCollaboration with Jazz Pharmaceuticals Accelerates Development of Early-Stage ADC Assets and Strengthens Financial Position
$100+ Million Follow-on Financing Provides Two-year Operating Runway
Presentations Accepted for ASH Annual Meeting Highlight Potential of Novel IGN Portfolio
IMGN632 Investigational New Drug Application Active
Conference Call to be Held at 8:00 a.m. ET Today
WALTHAM, Mass.--(BUSINESS WIRE)--... More
